Affiliation:
1. Department of Obstetrics and Gynecology Keio University School of Medicine Tokyo Japan
2. Department of Obstetrics and Gynecology Kyorin University Tokyo Japan
3. Department of Obstetrics and Gynecology Showa University Northern Yokohama Hospital Yokohama Japan
4. Department of Obstetrics and Gynecology Nagasaki University Hospital Nagasaki Japan
5. Department of Obstetrics and Gynecology Nippon Medical School Tokyo Japan
6. Department of Obstetrics and Gynecology Sapporo Medical University School of Medicine Sapporo Japan
Abstract
AbstractObjectiveThis study aimed to investigate the obstetric outcomes of transabdominal cerclage (TAC) in Japan.MethodsQuestionnaires on TAC were sent to 183 institutions performing high‐quality perinatal management in Japan. As a first‐step questionnaire, we asked whether TAC was performed between January 1, 2011, and December 31, 2022. In the second step of the questionnaire, the characteristics of all cases were asked from all institutions in which TAC was performed.ResultsThe response rate for the first survey was 59% (108/183). Of the 108 institutions, 27 performed TAC (25%) in 133 pregnancies. Of these 27 institutions, 19 responded to the second survey. One hundred twenty‐five pregnancies were included in this study, five of which were aborted (gestational weeks <22 weeks), and 69 babies were born after 37 gestational weeks (55%). Eighty‐two open abdominal cerclages were performed at 17 institutions and 43 laparoscopic TACs at three institutions. There were no differences in the age at TAC, gestational weeks at TAC, operative time of TAC, gestational weeks at delivery, incidence rate of second‐trimester loss, or preterm delivery (before 37 gestational weeks) rate between the two groups. However, blood loss during open TAC was greater than that during laparoscopic TAC.ConclusionTAC is a rare surgery for cervical insufficiency in Japan. TAC may be a safe and useful method for preventing second‐trimester loss and preterm delivery in high‐risk patients. TAC may also be a key option in Japan to improve perinatal outcomes in patients with cervical insufficiency.